Plain-English translation of NCT06669299 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is for people with implanted heart devices who had a procedure called ablation to treat dangerous irregular heartbeats (ventricular tachycardia). After the first ablation seemed successful, a special heart test showed the dangerous rhythm came back. The trial will randomly assign you to either receive a second ablation procedure or to take anti-arrhythmia medication instead, to see which approach better prevents the rhythm from returning.
Even when an ablation procedure appears to work, dangerous heart rhythms can return in some patients. Doctors don't yet know whether doing a second ablation or using medication is the better choice to keep patients safe long-term.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll be randomly assigned to one of two groups: either you'll receive a second ablation procedure, or you'll start taking anti-arrhythmia medication. Both groups will have heart rhythm tests and follow-up visits to track whether the dangerous rhythms return. The study will compare how well each approach works over time at preventing your heart rhythm problems from coming back.
AI-generated summary from trial data · Sep 17, 2026 · Not medical advice
Italy